At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HIMS Hims & Hers Health Inc.
Market Closed 12-20 16:00:00 EST
26.20
-0.16
-0.61%
盘后26.38
+0.18+0.69%
19:59 EST
High27.13Low25.31Vol17.30M
Open26.04D1 Closing26.36Amplitude6.90%
Mkt Cap5.72BTradable Cap4.96BTotal Shares218.48M
T/O453.80MT/O Rate9.14%Tradable Shares189.16M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Hims & Hers Health Shares Fall on FDA Declaration of End to Tirzepatide Shortage
MT Newswires Live  ·  12-20 19:44
Hims & Hers Health Shares Fall on FDA Declaration of End to Tirzepatide Shortage
Stock Track | Hims & Hers Health Inc (HIMS) Plunges 5.12% Pre-market on Eli Lilly's Weight Loss Drug Relief
Stock Track  ·  12-20 17:52
Stock Track | Hims & Hers Health Inc (HIMS) Plunges 5.12% Pre-market on Eli Lilly's Weight Loss Drug Relief
Why Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc (MSTR) Plunged Today
Insider Monkey  ·  12-20 07:14
Why Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc (MSTR) Plunged Today
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next
Yahoo Finance  ·  12-20 04:57
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next
FDA Says Shortage of Eli Lilly's Zepbound is Over, But Gives Compounders a Grace Period -- Barrons.com
Dow Jones  ·  12-20 01:16
FDA Says Shortage of Eli Lilly's Zepbound is Over, But Gives Compounders a Grace Period -- Barrons.com
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
Blockhead  ·  12-20 00:22
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
Eli Lilly's Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com
Dow Jones  ·  12-19 23:14
Eli Lilly's Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com
Hims & Hers Health Shares Fall 8.5% After US FDA Says Lilly's Weight-Loss Drug Shortage Resolved
THOMSON REUTERS  ·  12-19 23:04
Hims & Hers Health Shares Fall 8.5% After US FDA Says Lilly's Weight-Loss Drug Shortage Resolved
The Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com
Dow Jones  ·  12-19 23:02
The Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com
Hims & Hers falls -12.0%
TIPRANKS  ·  12-19 22:50
Hims & Hers falls -12.0%
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
MT Newswires Live  ·  12-18
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Stock Track | Hims & Hers Health Soars 5.15% as Morgan Stanley Initiates Coverage with Overweight Rating
Stock Track  ·  12-17
Stock Track | Hims & Hers Health Soars 5.15% as Morgan Stanley Initiates Coverage with Overweight Rating
Morgan Stanley Initiates Hims & Hers Health at Overweight
MT Newswires Live  ·  12-17
Morgan Stanley Initiates Hims & Hers Health at Overweight
Hims & Hers Health Initiated at Overweight by Morgan Stanley
Dow Jones  ·  12-17
Hims & Hers Health Initiated at Overweight by Morgan Stanley
Stock Track | Hims & Hers Health (HIMS) Plummets 5.03% as Competition Intensifies in Weight-Loss Drug Market
Stock Track  ·  12-16
Stock Track | Hims & Hers Health (HIMS) Plummets 5.03% as Competition Intensifies in Weight-Loss Drug Market
The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect. -- Barrons.com
Dow Jones  ·  12-16
The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect. -- Barrons.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)
TIPRANKS  ·  12-16
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)
Truist Financial Gives a Hold Rating to Hims & Hers Health (HIMS)
TIPRANKS  ·  12-13
Truist Financial Gives a Hold Rating to Hims & Hers Health (HIMS)
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
Business Wire  ·  12-12
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
BUZZ-Hims & Hers falls after Lilly to offer single-dose Zepbound vials on telehealth platform Ro
Reuters  ·  12-12
BUZZ-Hims & Hers falls after Lilly to offer single-dose Zepbound vials on telehealth platform Ro

Introduction

Company Name.
Hims & Hers Health Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Oaktree Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the industrial and consumer sectors. The company was founded in 2019 and is based in Los Angeles, California.
Issue price:
--